Medical Devices

Request for TOC Request for Sample
BUY NOW

Global Transcatheter Pulmonary Valve Market - Industry Trends and Forecast to 2028

Medical Devices | Upcoming Report | Oct 2021 | Global | 350 Pages | No of Tables: 220 | No of Figures: 60

Report Description

Global Transcatheter Pulmonary Valve Market, By Application (Cardiac Anomaly, Pulmonary Atresia, Pulmonary Stenosis, Pulmonary Regurgitation, Tetralogy of Fallot, Truncus Arteriosus and Others), Technology (Balloon-Expanded and Self-Expanded), Raw Materials (Synthetic and Tissue Engineered), End Use (Adult and Pediatric), and Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of the Middle East & Africa) Industry Trends and Forecast to 2028

Get Exclusive Sample Copy of this Report Here

Market Analysis and Insights: Global Transcatheter Pulmonary Valve Market

The transcatheter pulmonary valve market is expected to witness market growth at a rate of 6.12% in the forecast period of 2021 to 2028 and is expected to reach USD 201.00 million by 2028. Data Bridge Market Research report on the transcatheter pulmonary valve market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while impacting the market’s growth. The rise in the incidence of various cardiovascular diseases such as rheumatic heart disorders, hypertensive heart diseases, cerebrovascular diseases, and inflammatory heart diseases is escalating the growth of transcatheter pulmonary valve market.

Transcatheter Pulmonary Valve therapy is generally known to replace the pulmonary valve function while suspending open-heart surgery for as long as possible. It has become the treatment of choice in maximum of congenital heart disease patients.

Major factors that are expected to boost the growth of the transcatheter pulmonary valve market in the forecast period are the rise in the population with heart valve disorders and the increasing need for pulmonary valve replacement. Furthermore, the technological development in the valve replacement procedures and the rise in the burden of congenital heart disease is further anticipated to propel the growth of the transcatheter pulmonary valve market. Moreover, the growing of the elderly population is further estimated to cushion the growth of the transcatheter pulmonary valve market. On the other hand, substitute technologies are further projected to impede the growth of the transcatheter pulmonary valve market in the timeline period.

In addition, the growing alertness regarding the transcatheter pulmonary valve therapy will further provide potential opportunities for the growth of the transcatheter pulmonary valve market in the coming years. However, the strict regulations might further challenge the growth of the transcatheter pulmonary valve market in the near future.

This transcatheter pulmonary valve market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the transcatheter pulmonary valve market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you take an informed market decision to achieve market growth. 

Global Transcatheter Pulmonary Valve Market Scope and Market Size

The transcatheter pulmonary valve market is segmented on the basis of application, technology, raw materials and end use. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them in making strategic decisions for the identification of core market applications. 

  • On the basis of application, the transcatheter pulmonary valve market is segmented into cardiac anomaly, pulmonary atresia, pulmonary stenosis, pulmonary regurgitation, tetralogy of fallot, truncus arteriosus and others.
  • On the basis of technology, the transcatheter pulmonary valve market is segmented into balloon-expanded and self-expanded.
  • On the basis of raw materials, the transcatheter pulmonary valve market is segmented into synthetic and tissue engineered.
  • On the basis of end use, the transcatheter pulmonary valve market is segmented into adult and pediatric.

Transcatheter Pulmonary Valve Market Country Level Analysis

The transcatheter pulmonary valve market is analyzed, and market size insights and trends are provided by country, application, technology, raw materials and end use as referenced above.      

The countries covered in the transcatheter pulmonary valve market report are the U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

 North America dominates the transcatheter pulmonary valve market due to the occurrence of the highly developed healthcare sector. Furthermore, the rise in the incidence of disorders such as pulmonary stenosis and regurgitation will further boost the growth of the transcatheter pulmonary valve market in the region during the forecast period. Asia-Pacific is projected to observe significant amount of growth in the transcatheter pulmonary valve market due to the constant clinical trials with the current product base. Moreover, the increase in the need for innovative heart valves and growing elderly population is further anticipated to propel the growth of the transcatheter pulmonary valve market in the region in the coming years.

The country section of the transcatheter pulmonary valve market report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as consumption volumes, production sites, and volumes, import-export analysis, price trend analysis, cost of raw materials, downstream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.

Healthcare infrastructure growth installed base and new technology penetration

The transcatheter pulmonary valve market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the transcatheter pulmonary valve market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the transcatheter pulmonary valve market. The data is available for the historic period 2010-2019.

Competitive Landscape and Transcatheter Pulmonary Valve Market Share Analysis

The transcatheter pulmonary valve market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to the transcatheter pulmonary valve market.

The major players covered in the transcatheter pulmonary valve market report are Boston Scientific Corporation, Braile Biomédica, CryoLife, Inc., Edwards Lifesciences Corporation, JenaValve, LivaNova PLC, Medtronic, VENUS MEDTECH, SYMETIS, Colibri Heart Valve, LLC, Xeltis AG, Direct Flow Medical, Inc., Jude Medical Inc., Lepu Medical Technology (Beijing) Co., Ltd.., Commonwealth Edison Company, Labcor Laboratórios Ltda., ValveXchange, Inc., TTK HealthCare, among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-

Table of Content

Please fill in the below form for detailed Table of Content

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

List of Table

Please fill in the below form for detailed List of Table

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

List of Figure

Please fill in the below form for detailed List of Figure

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

View Infographics

Please fill in the below form for detailed Infographics

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country
CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19